| name | endo-visual-field-optic-chiasm |
| description | Suggests performing formal visual field testing when imaging reveals tumor abutting the optic chiasm to evaluate for visual pathway compression. Trigger phrases include MRI or CT showing tumor-chiasm contact. |
Perform visual field testing when tumor abuts optic chiasm
STEP 1 — Gather Information
Obtain a pituitary MRI (or CT if MRI contraindicated) and assess whether the tumor abuts or compresses the optic chiasm.
STEP 2 — Rule In / Rule Out
If imaging shows tumor-chiasm abutment, proceed to visual field testing; if no abutment is seen, formal visual field testing is not required per this guideline (though clinical judgment may still warrant it).
STEP 3 — Classify or Stratify
Perform automated perimetry (e.g., Humphrey 24‑2 or 30‑2) and classify the visual field as normal or abnormal (e.g., bitemporal hemianopia, unilateral defect, or diffuse loss).
STEP 4 — Decide
If the visual field is abnormal, expedite neurosurgical referral for decompression; if normal, schedule routine clinical and imaging follow‑up per acromegaly management.
Clinical Guardrails / Mimics / Pitfalls
Do not rely solely on patient‑reported visual symptoms, as chiasmal lesions can be asymptomatic until advanced; avoid using only confrontation testing, which misses subtle defects; do not delay testing when imaging shows contact, even if visual acuity is normal.
Concrete Clinical Example
A 48‑year‑old with acromegaly has an MRI showing a 12 mm macroadenoma abutting the optic chiasm; formal visual field testing reveals a bitemporal superior quadrantanopia, prompting urgent transsphenoidal surgery.
Source: Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700
